Anxiety Disorders

Disease

Related News

Study Links Teen Cannabis Use to Higher Risk of Mental Health Disorders

A large Kaiser Permanente study of 463,396 adolescents found those using cannabis were twice as likely to develop psychotic or bipolar disorders, with elevated risks for depression and anxiety. The research suggests adolescence is a vulnerable period for cannabis-related mental health harms, though causality remains complex.

Psychedelic Therapies Advance in Depression Trials with Mixed Results

Compass Pathways reports positive Phase 3 results for synthetic psilocybin in treatment-resistant depression, while a Phase 2 trial demonstrates rapid antidepressant effects from single-dose DMT. Both studies show modest efficacy signals amid growing pharmaceutical interest in psychedelic compounds.

Related Clinical Trials

NCT ID Title Status Phase
NCT07576686

AI-Guided CBT for Depression and Anxiety

RECRUITING NA
NCT07545070

The Efficacy of an AI-Based Rehabilitation Treatment in Patients With Anxiety Disorders

NOT_YET_RECRUITING NA
NCT07540585

MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal Patients

NOT_YET_RECRUITING
NCT07522814

"Educational Intervention for Tokophobia in Pregnant Women"

COMPLETED NA
NCT07458100

The STEP-MIED Trial: Digital Stepped-Care for Emotional Disorders

RECRUITING NA
NCT07244484

Closed-Loop Neurofeedback Targeting the Left Dorsolateral Prefrontal Cortex for Cardiac Autonomic Modulation in Coronary Artery Disease With Anxiety

RECRUITING NA
NCT07238920

Closed-Loop Neurofeedback Targeting the Right Dorsolateral Prefrontal Cortex for Cardiac Autonomic Modulation in Coronary Artery Disease With Anxiety

RECRUITING NA
NCT07203027

Quantifying Multi-step Avoidance in Anxiety

NOT_YET_RECRUITING NA
NCT07145307

Personalized Digital Treatment for Adolescent Anxiety: A Feasibility Trial

RECRUITING NA
NCT07028216

Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method

RECRUITING NA